Literature DB >> 9759631

Heparin regulates ICAM-1 expression in human endothelial cells: an example of non-cytokine-mediated endothelial activation.

S J Miller1, A M Hoggat, W P Faulk.   

Abstract

Activated endothelial cells up-regulate the expression of several molecules on their plasma membranes, including intercellular adhesion molecule-1 (ICAM-1). The role of heparin in regulating endothelial cell gene expression is unclear. We thus have investigated the ability of heparin to regulate ICAM- gene expression by using flow cytometry and the ribonuclease protection assay with human umbilical vein and aortic endothelial cells cultured in growth medium supplemented with 90 [microg/ml heparin (heparin-sufficient, HS) or in growth medium without added heparin (heparin-deficient, HD). We found that HD medium increased plasma membrane protein and mRNA for ICAM-1 but not for HLA-DR, even though both ICAM-1 and HLA-DR protein and mRNA were inducible by gamma interferon (IFN-gamma). In addition, phorbol ester and IFN-gamma increased the expression of plasma membrane ICAM-1 or ICAM-1 and HLA-DR, respectively, more in HD medium than in HS medium. We found that the HD-mediated increase of ICAM- mRNA was reversible by the addition of heparin, and that the half-life of ICAM-1 mRNA was the same in both HS- and HD-treated cells. Also, heparin was found to suppress increases in ICAM-1 mRNA at a concentration as low as 5 microg/ml. These findings indicate that heparin deficiency induces endothelial activation characterized by increased ICAM-1, and that such induction is not dependent on cytokines or endotoxin. The modulation of ICAM-1 expression by heparin appears to occur at the transcriptional level. Thus, heparin may have a role in regulating endothelial function by affecting the expression of ICAM-1, thereby impacting upon the trans-endothelial trafficking of leukocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759631

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Blockade of leucocyte function-associated antigen-1 (LFA-1) decreases lymphocyte trapping in the normal pulmonary vasculature: studies in the isolated buffer-perfused rat lung.

Authors:  A Klemm; T Tschernig; L Ermert; A Althoff; M Merkle; A Gebert; M Ermert; W Seeger; R Pabst
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention.

Authors:  Nawar A Alkhamesi; Paul Ziprin; Katherine Pfistermuller; David H Peck; Ara W Darzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery.

Authors:  Katsuhiro Nagata; Kenichiro Kumasaka; Kevin D Browne; Shengjie Li; Jesse St-Pierre; John Cognetti; Joshua Marks; Victoria E Johnson; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2016-12       Impact factor: 3.313

4.  Activated Syndecan-1 shedding contributes to mice colitis induced by dextran sulfate sodium.

Authors:  Xia Wang; Ye Chen; Yugang Song; Shaoheng Zhang; Xiaoyun Xie; Xianfei Wang
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

5.  Peritoneal nebulizer: a novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence.

Authors:  N A Alkhamesi; P F Ridgway; A Ramwell; P W McCullough; D H Peck; A W Darzi
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

6.  Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.

Authors:  Na Young Yi; Donna R Newman; Huiying Zhang; Helena Morales Johansson; Philip L Sannes
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

7.  Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.

Authors:  Shengjie Li; Rachel Eisenstadt; Kenichiro Kumasaka; Victoria E Johnson; Joshua Marks; Katsuhiro Nagata; Kevin D Browne; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2016-03       Impact factor: 3.313

8.  Early heparin administration after traumatic brain injury: Prolonged cognitive recovery associated with reduced cerebral edema and neutrophil sequestration.

Authors:  Katsuhiro Nagata; Kevin D Browne; Yujin Suto; Kenichiro Kumasaka; John Cognetti; Victoria E Johnson; Joshua Marks; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.697

9.  Mast Cells Exert Anti-Inflammatory Effects in an IL10-/- Model of Spontaneous Colitis.

Authors:  E M Lennon; L B Borst; L L Edwards; A J Moeser
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

Review 10.  Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection.

Authors:  Ashleigh R Murphy-Schafer; Silke Paust
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.